172 results
Page 7 of 9
8-K
EX-99.1
ygigp3tllsv8xp8c
2 May 19
Other Events
7:10am
8-K
EX-99.1
q3w ff8dxeidhffcnqv5
2 Apr 19
Other Events
8:10am
8-K/A
EX-99.1
4kvn5e0 nt6pa
27 Feb 19
CORRECTING and REPLACING — Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
5:16pm
8-K
EX-99.1
btse6cy1d92t
27 Feb 19
Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
7:43am
8-K
EX-99.1
lft2s6ws8 5f6zdmg3
7 Jan 19
Other Events
7:40am
8-K
EX-99.1
n0k5lcdsf
12 Dec 18
Adaptimmune Announces that Gwen Binder will leave in January 2019
8:39am
8-K
EX-99.1
6nuho
6 Nov 18
Adaptimmune Reports Third Quarter 2018 Financial Results and Business Update
7:36am
8-K
EX-99.1
3jwbe2fcpw9cs
22 Oct 18
Other Events
8:38am
8-K
EX-99.1
mo1vy4vcmdql1 7t
7 Sep 18
Adaptimmune Therapeutics plc Announces Closing of Registered Direct Offering of American Depositary Shares
12:00am
8-K
EX-99.1
5ounczuw
15 Aug 18
Third Dosing Cohort to be initiated in MAGE-A4 SPEAR T-cell Basket Study After Favorable Review of Safety from One Billion Cell Dose Cohort
7:39am
8-K
EX-99.1
9yuspeoyczl1xzpj
2 Aug 18
Adaptimmune Reports Second Quarter 2018 Financial Results and Business Update
7:41am
8-K
EX-99.1
omi9ucgt06zv gl5yzv
24 Jul 18
GSK and Adaptimmune Complete Transition of NY-ESO SPEAR T-cell Therapy Program to GSK
7:36am
8-K
EX-99.1
62rkt xjjczhh9yhp
18 Jul 18
Other Events
5:01pm
8-K
EX-99.1
khoz ae0np1t
9 May 18
Adaptimmune Reports First Quarter 2018 Financial Results and Business Update
7:39am